Working to Increase Awareness of Heparin-Induced Thrombocytopenia (HIT)
Heparin-induced thrombocytopenia (HIT) is a serious complication that has potentially devastating consequences. Despite a number of new therapies, research has shown that HIT is not always detected or managed optimally in hospital settings. This initiative will provide health care professionals who treat patients receiving heparin anticoagulation education on HIT risk factors, presentation, diagnosis and management, as well as for timely information on new and emerging therapeutic options.
Learning Objectives
- Identify risk factors associated with heparin-induced thrombocytopenia (HIT) in the hospital setting and apply this knowledge toward guideline adherence for accurate HIT screening and identification
- Review the most recent guidelines for early recognition and accurate diagnosis of HIT and demonstrate an awareness of the current recommendations surrounding management options
- Utilize practical tools for raising HIT awareness and improving its management in the hospital setting
New – Expert On Call
Stanley A. Nasraway, Jr, MD, FACP, FCCM
Professor of Medicine
Harvard Medical School
Director, Surgical Intensive Care Unit
Professor, Surgery, Anesthesia and Medicine
Tufts University School of Medicine
Boston, Massachusetts
Each month, an expert in HIT will be "On Call" to answer your HIT-related questions. Check back each month for updates!
